Serological Assays for the detection and characterization of influenza viruses
ID: 75D30125R73211Type: Presolicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFCENTERS FOR DISEASE CONTROL AND PREVENTIONCDC OFFICE OF ACQUISITION SERVICESATLANTA, GA, 30333, USA

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

MEDICAL- LABORATORY TESTING (Q301)

Set Aside

Total Small Business Set-Aside (FAR 19.5) (SBA)

Original Source

https://sam.gov/opp/84e018421ede492b8b79bd974764c756/view
Timeline
    Description

    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking contractors for the provision of serological assays aimed at detecting and characterizing influenza viruses. This contract encompasses a 12-month base period with four additional 12-month option periods, focusing on testing immunological responses from human samples collected during vaccine effectiveness studies, randomized controlled trials, and outbreak investigations using Hemagglutination Inhibition (HAI) assays. The services are critical for understanding vaccine efficacy and managing influenza outbreaks, with the government supplying necessary standard operating procedures, proficiency panels, and controls to ensure proper assay performance. Interested parties should contact Jennifer Gartzke at jgartzke@cdc.gov or 404-498-0020 for further details, as this opportunity is set aside for small businesses under the SBA guidelines.

    Point(s) of Contact
    Jennifer Gartzke
    (404) 498-0020
    jgartzke@cdc.gov
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    Serological Assays for the detection and characterization of influenza viruses
    Currently viewing
    Presolicitation
    Similar Opportunities
    Phase I - Serological Assays for the detection and characterization of influenza viruses
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is soliciting proposals for a contract focused on the development and execution of serological assays for the detection and characterization of influenza viruses. The primary objectives include performing hemagglutination inhibition assays on human sera for vaccine effectiveness studies and creating a new serology platform that matches the capabilities of existing assays, with an expected testing volume of approximately 6,000 samples annually. This initiative is crucial for enhancing public health responses to influenza through improved detection methodologies and is set within a framework that emphasizes small business participation and adherence to federal acquisition regulations. Interested parties can contact Jennifer Gartzke at jgartzke@cdc.gov or by phone at 404-498-0020 for further details, with the contract performance period commencing on April 28, 2025, and extending through optional periods thereafter.
    Diagnostic Test Development and Production for Emergency Response
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking proposals for the development and production of diagnostic tests aimed at enhancing emergency response capabilities for public health threats. The procurement involves multiple tasks, including the rapid development and validation of Nucleic Acid Amplification Tests for selected pathogens, regulatory submissions for Emergency Use Authorization (EUA), and the manufacturing of tests to meet outbreak demands. This initiative is critical for bolstering the national laboratory system's readiness and efficiency in addressing public health emergencies. Interested vendors must submit their proposals by December 13, 2024, with a maximum contract value of $148 million and a minimum order of $10,000. For further inquiries, vendors can contact Shayna Connery at xvj9@cdc.gov or Austin Pagliaccetti at zsm6@cdc.gov.
    Rapid Pandemic Influenza and Emergency Infectious Disease Vaccine Development and Response Capability
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Office of Assistant Secretary for Preparedness and Response (BARDA), is seeking proposals for the "Rapid Pandemic Influenza and Emergency Infectious Disease Vaccine Development and Response Capability" through a Special Notice. The objective of this procurement is to establish a long-term partnership focused on developing a flexible and rapid response capability for vaccine development against pandemic influenza and other priority pathogens, initially emphasizing influenza mRNA vaccine development. This initiative is critical for enhancing the nation's preparedness and response to emerging infectious diseases, ensuring readiness to pivot quickly in the face of public health threats. Interested parties can access the full Request for Project Proposals and additional consortium information at www.rrpv.org, and inquiries can be directed to Rebecca Harmon at rebecca.harmon@ati.org.
    CDC DFWED NARST Sensititre Supplies
    Active
    Health And Human Services, Department Of
    The Centers for Disease Control and Prevention (CDC) is seeking to award a sole source contract for antimicrobial resistance testing supplies, specifically Sensititre™ broth microdilution testing products, from ThermoFisher Scientific. This procurement is essential for the National Antimicrobial Resistance Monitoring System (NARMS), which has utilized these proprietary materials since 1996 to ensure a standardized approach to monitoring enteric bacteria resistance. The unique nature of these supplies necessitates this sole source approach, as alternatives would require significant investments in new equipment and validation processes, potentially disrupting critical surveillance efforts. Interested parties may respond within 15 days to express their interest, with proposals directed to contract specialist Ashley Williams at dal3@cdc.gov.
    Increasing Community Access to Testing and Treatment (ICATT) Pharmacy Services
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Centers for Disease Control and Prevention (CDC), is seeking partnerships with private contractors for the Increasing Community Access to Testing, Treatment, and Prevention (ICATT) Pharmacy Services program, which will run from June 1, 2025, to May 31, 2030. The procurement aims to provide comprehensive healthcare services, including nationwide testing, medical assessments, therapeutics, vaccinations, and emergency response capabilities, particularly targeting under-resourced communities. This initiative builds on the successful efforts during the COVID-19 pandemic and emphasizes the importance of public-private partnerships in enhancing public health infrastructure and accessibility. Interested contractors should submit their detailed responses to the Request for Information by October 22, 2024, with inquiries due by November 4, 2024; for further information, contact Dawn Redman at dredman@cdc.gov or Jorge Morales at xvx7@cdc.gov.
    Notice of Intent to Sole Source - Biosearch Technologies
    Active
    Health And Human Services, Department Of
    The Centers for Disease Control and Prevention (CDC) intends to negotiate a sole source contract with Biosearch Technologies, Inc. for the production of PCR kits essential for the Laboratory Response Network (LRN). The procurement aims to secure proprietary reagents necessary for detecting biothreat and emerging infectious disease agents, which are critical for the preparedness and response capabilities of various federal and state agencies. These kits, which must adhere to FDA quality standards, are vital for high-security laboratories in identifying potential bioterrorism agents and ensuring public health safety. Interested parties may submit capability statements or proposals to Matthew Nelson at mnelson2@cdc.gov by December 3, 2024, at 3:30 PM EST for consideration.
    SERVICE AGREEMENT FOR A FACSYMPHONY S6 SORTER
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through the National Institute of Allergy and Infectious Diseases (NIAID), is seeking quotes for a service agreement for a FACSymphony S6 sorter and associated lasers. The contract aims to ensure the maintenance and optimal operation of flow cytometers and related equipment critical for research on immune responses in HIV- and SIV-infected samples. This service agreement is essential for the uninterrupted functionality of the equipment used in the Vaccine Research Center's Flow Cytometry Core, with a performance period from February 1, 2025, to January 31, 2026. Interested vendors must submit their quotes by November 25, 2024, at 12:00 PM EST, and can contact Mildred Moss at mildred.moss@nih.gov or Tonia Alexander at talexander@niaid.nih.gov for further information.
    Notice of the Intent to Sole Source to Roche Diagnostics for the purchase of the Cobas 5800 Classic Service Package.
    Active
    Health And Human Services, Department Of
    The Centers for Disease Control and Prevention (CDC) intends to award a sole source firm fixed price purchase order to Roche Diagnostics for the Cobas 5800 Classic Service Package. This procurement is necessary due to the exclusive licensing agreements and proprietary data restrictions associated with the Cobas 5800 equipment, which limits service provision to Roche Diagnostics alone. The services are critical for maintaining the functionality of laboratory instruments essential for public health operations. Interested parties may express their interest and capability to respond to this requirement by emailing the contract specialist, Robert Iaropoli, at zlb5@cdc.gov, by 6:30 AM EDT on December 2, 2024. Responses received within this timeframe will be considered by the government, although this notice does not constitute a request for competitive quotations.
    SERVICE AGREEMENT FOR A FACSYMPHONY S6 SORTER
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking a qualified contractor to provide a service agreement for a FACSymphony S6 sorter and associated lasers, essential for maintaining optimal operation of flow cytometry equipment used in critical research. The contract includes provisions for preventive maintenance inspections, unlimited service visits, and priority onsite scheduling to minimize downtime, ensuring that the equipment remains functional for ongoing research into immune responses in HIV- and SIV-infected samples. Interested vendors must submit their quotes via the NIAID electronic Simplified Acquisition Submission System (eSASS) by November 25, 2024, with the contract period set from February 1, 2025, to January 31, 2026. For further inquiries, vendors can contact Mildred Moss at mildred.moss@nih.gov or Tonia Alexander at talexander@niaid.nih.gov.
    ATTUNE NXT AND CYTKICK SERVICE AGREEMENTS
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking to negotiate a service contract for the maintenance of an Attune NXT flow cytometer and Cytkick plate reader with Life Technologies. The one-year contract will include one annual preventative maintenance visit, covering parts, labor, travel for repairs, guaranteed response times, and technical support, essential for research in the Medical Virology Section focused on viral gene expression. Interested vendors are invited to submit capability statements by November 29, 2024, at 10:00 AM EST, via the NIAID's electronic Simplified Acquisition Submission System (eSASS), with the understanding that this notice does not constitute a request for proposal and does not obligate the government to award a contract. For further inquiries, vendors can contact Leah Hinson at leah.hinson@nih.gov.